Change of Name

Recorded: 2023-05-25 Pages: 12

Assignor

LABORATORIOS DEL DR. ESTEVE S.A.

Executed: 2018-06-25

Assignee

ESTEVE PHARMACEUTICALS, S.A.

PASSEIG DE LA ZONA FRANCA, 109, 4ª PLANTA, TORRE ESTEVE, BARCELONA, 08038, SPAIN

Covered Property (1)

4-[-2-[[5-methyl-1-(2-naphtalenyl)-1H-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates

Patent: 47,214 →

Application: 15/616,347 →

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.